SYNOPSIS Two radioimmunoassays for the determination of serum triiodothyronine (T3) were developed. The assay of T3 in unextracted serum had several advantages over the assay on extracted serum and was chosen for the routine determination of T3 in serum from 117 patients requiring assessment of their thyroid status.
The application of radioimmunological methods to the measurement of serum triiodothyronine (T3) in health and disease has revealed a previously unsuspected role for this hormone in the maintenance of the euthyroid state. Clinically, serum T3 estimations have been advocated for detecting early thyrotoxicosis (Hollander et al, 1971b) and have revealed a new variant of hyperthyroidism, 'T3-toxicosis', in which patients diagnosed unequivocally as thyrotoxicosis have normal serum thyroxine (T4) levels but increased concentrations of T3 (Sterling et al, 1970) . In addition it is now clear that treatment of hyperthyroidism, by surgery or with drugs, leads to preferential serum T3 production (Bellabarba and Tremblay, 1972) as do low iodine diets (Hollander et al, 1971a) .
The accuracy of methods based on protein-binding techniques for T3 analysis has been impaired by interference from in vivo T3-binding proteins, in particular thyroid hormone-binding globulin (TBG).
When interference from this source has gone unrecognized high serum values for T3 have been reported (Gharib et al, 1970) .
Several reagents capable of blocking plasma protein T3-binding sites have been reported and these include T4 (Chopra et al, 1971) (Mitsuma et al, 1971) , diphenylhydantoin (Lieblich and Utiger, 1972) , salicylate (Larsen, 1971) , and 8-anilino-naphthalene-sulphonic acid (Mitsuma et al, 1972) . Each has drawbacks; either they are unstable in solution or they interfere with the antigen-antibody reaction (Hufner and Hesch, 1973a) . Recently sodium ethylmercurithiosalicylate (Merthiolate, thiomersal) has been shown to inhibit the binding of T3 to thyroxine-binding proteins (Bellabarba and Tremblay, 1973) , and this reagent has been incorporated into radioimmunoassays for triiodothyronine (Hufner and Hesch, 1973b; Kirkegaard et al, 1974) . In the presence of serum proteins merthiolate does not influence the antibody-hapten reaction (Kanagasabapathy and Wellby, 1974) .
This report describes a comparison of two radioimmunoassays for serum T3, the alcoholic extraction assay being used as a reference method for the assay on unextracted serum. Merthiolate was used to block the TBG binding sites. A preliminary clinical evaluation of the results on patients for whom routine in vitro thyroid function tests have been requested is presented.
Material and Methods

BARBITONE-ALBUMIN-MERTHIOLATE BUFFER
Barbitone buffer (0-1 mol/l) at pH 8-65 contained Merthiolate (sodium ethylmercurithiosalicylate, 5 00 mmol/l) and bovine albumin (5 g/l). All solutions were stored at 4°C unless otherwise stated.
LABELLED TRIIODOTHYRONINE
High specific activity 1251-L-triiodothyronine (ca 400 mCi/mg) in 50% propylene glycol was purchased from Abbott Laboratories and further purification was found to be unnecessary. It was diluted to about 500 pmol/l with barbitone-albumin-Merthiolate buffer. STANDARDS L-3', 3, 5-triiodothyronine (B grade) was obtained from Calbiochem Ltd, and its molar extinction coefficient (Gemmill, 1955) In some experiments alcoholic extracts of serum were prepared by the addition of two volumes of ice-cold ethanol and spinning down the precipitated proteins. Recovery of added 125I-T3 under these conditions was 100% and confirms the results of Patel and Burger (1973) . Duplicate 50 I-l aliquots of the supernatant were used directly in the radioimmunoassay.
Thyroxine was measured by the Abbot Tetrasorb procedure controlled as previously described (Watson and Lees, 1973) . Sera showing T4 levels that were close to upper or lower normal limits were assayed for 'free thyroxine index' (FTI). The latter was calculated as total T4 divided by the unsaturated thyroid hormone-binding globulin level, expressed as a fraction of a laboratory pooled serum standard and measured by the Thyopac-3 test (Radiochemical Centre).
Radioimmunoassay
To 50 pl of the unknowns, standards, and 'zero' standards were added 100 ,ul of 1251-T3 solution and 100 pl of diluted antiserum. For the unknowns and 'zero' standard a similar set of tubes was set up containing buffer instead of antiserum (blanks). After mixing and incubation overnight at 4°C or for one hour at 37°C, the tubes were equilibrated in an ice bath. A 500 pl aliquot of a well-stirred charcoal suspension at 2°C was forcibly added to each tube with the aid of an automatic syringe pipette. After incubation for 20 minutes the tubes were centrifuged at 4000 rev/min for 10 minutes and returned to the ice bath. The supernatants were removed by suction and the charcoal pellets counted in an LKB Wallac 8000 gamma counter for at least 60 seconds (ie, about 104 counts).
CALCULATIONS
All counts were automatically corrected for background.
Standards
The reciprocal of B, the fraction of T3 bound by the antibody, was calculated by the formula: in the euthyroid group. Very similar figures were calculated for the alcoholic extraction assay with the exception that ethanol tended to depress the binding in the low dose region of the standard curve (intercept 1/B was 1 887 ± 0 092, n = 10). A direct result of this effect was a reduction in the assay sensitivity (smallest detectable dose 11 ± 6 fmol).
NORMAL RANGE
The normal range (mean ± 2 SD) of serum T3 in 53 euthyroid outpatients was 1 92 ± 0-77 nmol/l (1 25 ± 0 50 ,ug/l). This agrees well with values found by most other investigators using radio- (Ekins et al, 1968) cControl serum at beginning and end of each run dCalculated by the duplicates method (Snedecor and Cochran, 1956) eNumber of duplicates. immunoassay but different TGB blocking agents. A small but consistent fall in serum T3 with increasing age was observed in the present study (figure) and confirms the earlier observations of Brunelle and Bohuon (1972) Two subjects, who admitted taking heroin, had raised serum T3 concentrations (3 4 and 3-6 nmol/l) but normal serum T4 levels (122 and 133 nmol/l) and normal FTI (7 5 and 8 4).
Discussion
A radioimmunoassay for the direct measurement of T3 in serum has been described and its performance compared with an alcoholic extraction assay. For routine use the direct assay was preferred, primarily because the time for antibody incubation could be reduced to one hour at 37°C and fewer pipetting steps were involved. Thus results could be obtained on the same working day with fewer potential sources group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from of error. In terms of accuracy the direct assay overestimated the T3 content on average by some 5 %. This value agres well with the 95% efficacy of Merthiolate in displacing T3 from TBG binding sites reported by Htifner and Hesch (1973a) and Kirkegaard et al (1974) .
A disturbing feature of the radioimmunological measurement of T3 in unextracted serum is the occurrence of low values in patients with hypoproteinaemia as a result of nephrotic syndrome, coeliac disease or senile malabsorption. Low serum T3 levels have also been detected in kwashiorkor. However, in the latter case this observation appears to be due to a methodological artefact, since no low T3 values were observed when sufficient T3-free normal serum was added to the immunoassay tube to make the serum protein level comparable to normal serum samples (van der Westhuyzen, 1973) . Thus before any reliance can be placed on serum T3 data from hypoproteinaemic patients it is essential that the immunoassay system be shown to be unaffected by large changes in serum protein levels. Further work is needed to elucidate this phenomenon. However, normal patient to patient variation in total serum protein content does not appear to affect the accuracy of the method significantly, and in practice it is the high serum T3 values that are of clinical importance.
Published ranges for euthyroid levels of serum T3 as determined by radioimmunoassay vary considerably, although workers have agreed that the mean lies between 1-5 and 2-3 nmol/l with a standard deviation of some 03 to 0-5 nmol/l. This interlaboratory variation could be due to methodological differences since the apparent serum T3 concentration depends to some extent upon the blocking agent used (Hufner and Hesch, 1973a) (Herrmann et al, 1974) . The authors concluded that reduced protein-binding of thyroid hormones, particularly T3, could be excluded as the cause of low serum T3 and T4 concentrations observed in aged patients.
At the present time the usefulness of serum T3 measurements in the routine diagnosis of thyroid disease is restricted to two well-defined areas. Where the clinical pattern indicates hyperthyroidism, but serum T4 level and the FTI are normal, measurement of serum T3 concentrations can confirm 'T3-toxicosis', and seven such patients were identified in the present series. Of these seven patients, four were diagnosed as 'early thyrotoxicosis'. The ability to provide biochemical support for this diagnosis is of great value and suggests that all patients for whom serum T4 estimations have been requested should also be screened for serum T3. An increased serum T3 level relative to the T4 concentration has been observed during treatment of hyperthyroidism (Bellabarba and Tremblay, 1972 ) and this occurred in four patients in the present study. In these cases measurement of serum T3 levels helps to define thyroid status.
Not all cases of increased serum levels of T3, however, appear to be associated with clinical evidence of hyperthyroidism. In this study two clinically euthyroid heroin addicts had high levels of serum T3 but normal T4 concentrations. Whether this reflects the pituitary-thyroid relationship seen in Pendred's syndrome (deafness and non-iodinedeficiency goitre) is not known, but Gomez-Pan et al (1974) recently reported such a patient with raised serum T3 concentrations and normal levels of serum T4. Interestingly an increased TSH response to thyrotropin releasing hormone (TRH) was observed in this patient. Studies in mice have shown that codeine, which has a chemical structure very similar to that of heroin, enhances the TSH response to TRH (Redding et al, 1966) . While caution must be exercised in drawing inferences from animal studies and applying them to the human it remains a possibility that heroin was having a similar effect in the patients addicted to this drug. However, in a series of clinically euthyroid heroin addicts studied by Webster et al (1973) an increased mean serum T4 level was observed as a result of an elevated serum TBG binding capacity. Serum T3 levels were not measured.
In conclusion, a preliminary clinical evaluation of serum T3 estimations in routine diagnostic use suggests that measurement of serum T3 levels would provide more information than T4 and should be requested in all cases of suspected hyperthyroidism and in patients undergoing therapy for thyroid disorders.
